Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 9.03 is in line with its 5-year average of 9.32, around the middle of its 5-year range (0.00–21.08).
As of the fiscal period ended Tuesday, June 30, 2026. 25.12% below its 12-month average of 12.06.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.03.
CURRENT RATIO
9.03
CURRENT RATIO AVG TTM
12.06
CURRENT RATIO AVG 3Y
9.30
CURRENT RATIO AVG 5Y
9.32
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-25.12%
CURRENT VS 3Y AVG
-2.90%
CURRENT VS 5Y AVG
-3.10%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+140.89%
vs the sector median at left
NewAmsterdam Pharma Company N.V.
Market Cap
$2.58B
Current Ratio
9.03
TTM Avg
12.06
3Y Avg
9.30
5Y Avg
9.32
Market Cap
$2.57B
Current Ratio
1.62
TTM Avg
1.73
3Y Avg
1.84
5Y Avg
1.83
Market Cap
$2.67B
Current Ratio
1.16
TTM Avg
1.32
3Y Avg
1.06
5Y Avg
0.97
Market Cap
$2.47B
Current Ratio
2.08
TTM Avg
2.13
3Y Avg
1.75
5Y Avg
1.92
Market Cap
$2.69B
Current Ratio
1.57
TTM Avg
1.27
3Y Avg
1.13
5Y Avg
1.28
Market Cap
$2.71B
Current Ratio
18.08
TTM Avg
24.41
3Y Avg
20.74
5Y Avg
20.74
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewAmsterdam Pharma Company N.V. (NAMS) | $2.58B | 9.03 | 12.06 | 9.30 | 9.32 |
| Privia Health Group, Inc. (PRVA)vs › | $2.57B | 1.62 | 1.73 | 1.84 | 1.83 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.58B | 14.57 | 8.96 | 7.17 | 6.28 |
| Neogen Corporation (NEOG)vs › | $2.60B | 3.82 | 3.57 | 3.75 | 5.68 |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.67B | 1.16 | 1.32 | 1.06 | 0.97 |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.47B | 2.08 | 2.13 | 1.75 | 1.92 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 1.57 | 1.27 | 1.13 | 1.28 |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.71B | 18.08 | 24.41 | 20.74 | 20.74 |
| Precigen, Inc. (PGEN)vs › | $2.69B | 4.58 | 3.92 | 3.08 | 3.40 |
| AtriCure, Inc. (ATRC)vs › | $2.73B | 4.22 | 3.80 | 3.72 | 4.10 |
Current Ratio
9.03
Quick Ratio
9.03
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 9.03 |
| 2026-03-31 | 9.76 |
| 2025-12-31 | 7.88 |
| 2025-09-30 | 12.57 |
| 2025-06-30 | 21.08 |
| 2025-03-31 | 19.98 |
| 2024-12-31 | 8.08 |
| 2024-09-30 | 10.61 |
| 2024-06-30 | 9.83 |
| 2024-03-31 | 8.17 |
| 2023-12-31 | 6.95 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 10.15 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 13.26 |
| 2022-09-30 | 13.26 |
| 2022-06-30 | 8.38 |
| 2022-03-31 | 8.38 |
| 2021-12-31 | 5.96 |
| 2021-09-30 | 5.96 |
| 2021-06-30 | 10.27 |
| 2021-03-31 | 6.73 |
| 2020-12-31 | 7.90 |
| 2020-09-30 | 0.72 |
| 2020-06-30 | 0.72 |
| 2020-03-31 | 0.72 |
